The counter-regulatory effect of adenosine, isoprenaline and selected cyclic AMP analogues on insulinstimulated 3-O-methylglucose transport and insulin binding were studied in rat fat-cells. Isoprenaline alone had no consistent effect on glucose transport in the presence of maximally effective insulin concentrations.
INTRODUCTION
Peripheral insulin resistance is rapidly induced in vivo by catecholamine infusion (Deibert & DeFronzo, 1980; Sacca et al., 1982; Lager et al., 1986) . Detailed studies have shown that catecholamines decrease the response to a maximally effective concentration of insulin and produce a marked rightward shift of the dose-response curve for insulin effects on peripheral glucose uptake (Lager et al., 1986) . Owing to the presence of spare receptors in most cells, a decreased maximal effect of insulin (decreased responsiveness) is usually due to a post-receptor perturbation, whereas a rightward shift in the dose-response curve (decreased sensitivity) may be due to either receptor or post-receptor defects (Kono & Barham, 1971) .
Studies with isolated fat-cells have shown that, in the absence of adenosine, ,?-adrenergic stimulation markedly inhibits the maximal effect of insulin on glucose transport. Adenosine accumulating in the incubation medium exerts a potent modulating effect on the ability of ,-adrenergic stimulation to inhibit insulin action (Green, 1983; Smith et al., 1984) . By using the D-glucose-inhibitable cytochalasin-B-binding technique it was shown that the inhibitory effect of fl-adrenergic stimulation was, in part, due to an impairment of the insulin-stimulated recruitment of glucose-transport units to the plasma membrane, as well as to a markedly decreased intrinsic activity of the glucose transporters (Smith et al., 1984) . ,?-Adrenergic stimulation has also been shown to inhibit the insulin-stimulated redistribution of IGFII-binding sites from the intracellular pool to the plasma membrane (Lonnroth et al., 1985a) . Furthermore, insulin binding to fat-cells is rapidly decreased by ,J-adrenergic stimulation (Lonnroth & Smith, 1983 , Pessin et al., 1983 Kirsch et al., 1983; Lonnroth et al., 1985b) . In order to characterize in detail the interaction between the adenylate cyclase system and the activation of glucose transport by insulin, the effect of ,J-adrenergic stimulation, adenosine, and different cyclic AMP analogues was studied on insulin binding and action. Furthermore, in order to evaluate the importance of the inhibitory nucleotide-binding protein (Ni), experiments were performed in cells exposed to pertussis toxin.
METHODS

Isolated adipocytes
Male Sprague-Dawley rats (150-170 g) were stunned and decapitated, and the epididymal fat-pads excised. 125I-insulin (0.05-0.12 nM) and different concentrations of unlabelled insulin (0-0.7,UM). After 20 or 60 min incubation at 37°C, the cells were separated from the incubation medium by centrifugation through silicone oil (Gammeltoft & Gliemann, 1973) . Insulin binding was expressed as the cell-associated insulin after subtracting non-specific binding, estimated as the amount of tracer not displaced by the presence of 0.7/,M unlabelled insulin. Lipolysis was measured in 100 #1 samples of the incubation medium by measuring the glycerol content enzymically as previously described in detail (Smith et al., 1984) . Fat-cell size and number were estimated as described previously (Smith et al., 1972) .
3-O-Methylglucose transport
The cells were preincubated in glucose-free medium with 4% (w/v) bovine serum albumin and different concentrations of insulin, isoprenaline, adenosine deaminase, N6-monobutyryl cyclic AMP and 8-bromo cyclic AMP as indicated. After 20 min 3-O-methylglucose transport was measured essentially as described by Whitesell & Gliemann (1979 
RESULTS
Effectiveness of pertussis-toxin treatment
The effectiveness of the pertussis-toxin treatment to inhibit the N1 action was examined in experiments where the ability of high GTP concentrations to inhibit the adenylate cyclase activity in crude membranes was measurecL; As shown in Fig. 17 
Effect of adenosine deaminase (ADA) and isoprenaline on insulin-stimulated glucose transport The inhibitory effect of isoprenaline and ADA, alone or in combination, on maximally insulin-stimulated glucose transport was studied in cells from animals injected with either saline or pertussis toxin (Table 1) . When added together with insulin, isoprenaline alone had no inhibitory effect, whereas ADA alone caused a slight inhibition. Isoprenaline and ADA together consistently inhibited the insulin effect (20-40%). Cells from pertussis-toxin-treated animals showed a lower basal transport activity and a decreased maximum response to insulin (by approx. 50 % ). However, the effect of insulin, expressed as relative increment in glucose transport, was unchanged. In these cells isoprenaline alone caused a marked inhibition of insulin action (approx. 70%) and no further effect was seen by the simultaneous addition of ADA (Table 1) .
Isoprenaline alone induced a 2-fold rightward shift of the dose-response curve for insulin (Table 2) . ADA alone exerted a similar effect (results not shown). A further decrease in the sensitivity to insulin was seen with the combination of isoprenaline and ADA (EC50 approx. 61 ,uunits/ml). Cells from pertussis-toxin-treated animals showed an insulin-sensitivity similar to that of untreated cells in the presence ofADA (EC50 approx. 17 ,uunits/ml). Isoprenaline alone induced a marked rightward shift in the dose-response curve for insulin (EC50 approx. 103 ,uunits/ml), with no additional effect produced by simultaneous addition of ADA (Table 2) .
Insulin binding
Cell-associated 1251-insulin measured under steadystate conditions after 60 min incubation with isoprenaline alone was decreased by approx. 30%. ADA alone was without effect, whereas the combination of isoproterenol and ADA decreased insulin binding by approx. 50%. Insulin binding in the absence of isoprenaline and ADA was unchanged in pertussis-toxin-treated cells. However, these cells were markedly sensitive to isoprenaline alone;
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and, in combination with ADA, by approx. 35% (Table   3 ). Isoprenaline alone decreased insulin binding even further (by approx. 45 % ) in pertussis-toxin-treated cells, but ADA had no additional effect (Table 3 ). The decrease in binding under these conditions was due to a decrease in the apparent number of receptors (Fig. 2) . Sensitivity to isoprenaline
The dose-response curve for the inhibitory effect of isoprenaline on insulin binding and insulin-stimulated glucose transport is shown in Fig. 3 . In control cells half-maximal inhibition of both insulin binding (Fig. 3a) and glucose transport (Fig. 3b) was seen at approx. 0.5 /M-isoprenaline. The dose-response curve for isoprenaline was shifted to the left in the presence of ADA (half-maximal effect at approx. 0.05 ,#M). Pertussis-toxintreated cells showed a further enhancement of their sensitivity to isoprenaline, irrespective of whether ADA was present or not (half-maximal effect at approx. 0.02 ,SM) (Figs. 3a and 3b ).
Effect of different cyclic AMP analogues
In order to elucidate the importance of cyclic AMP for the effects exerted by isoprenaline and ADA on both insulin binding and glucose transport, two different cyclic AMP analogues, N6-monobutyryl cyclic AMP and 8-bromo cyclic AMP, were used. The former analogue is highly resistant to hydrolysis by phosphodiesterase, whereas the latter is an excellent substrate (Beebe et al., 1984) . Comparing the inhibitory effect of these analogues on insulin action gives information about the potential cyclic-AMP-dependence of the effects elicited by ,-adrenergic stimulation. Furthermore, the importance of phosphodiesterase activation for the metabolic effect of insulin can also be elucidated. The relevance of this experimental model is further supported by the observation that the elevated intracellular cyclic AMP concentrations and activation of cyclic-AMP-dependent protein kinase effectively decrease the endogenous production of cyclic AMP . As shown in Table 4 , the two analogues were equipotent in stimulating lipolysis in rat fat-cells in the absence of insulin.
N6-Monobutyryl cyclic AMP produced a marked shift in the dose-response curve for insulin-stimulated glucose transport (EC50 approx. 100 gunits/ml), whereas it only exerted a small inhibitory effect on the maximal insulin response (Fig. 4a) . In contrast, the hydrolysable analogue 8-bromo cyclic AMP had only a marginal antagonistic effect on insulin-sensitivity and did not alter the responsiveness (Fig. 4a) . Evaluation of the doseresponse curve for the ability of insulin to overcome the inhibition exerted by N6-monobutyryl cyclic AMP showed that the half-maximal effect was also exerted at approx. 100 ,uunits/ml (Fig. 4b) . The inhibitory effect of N6-monobutyryl cyclic AMP and 8-bromo cyclic AMP on the dose-response curve for insulin action on glucose transport was similar in pertussis-toxin-treated cells and in control cells (results not shown). Under both conditions, N6-monobutyryl cyclic AMP produced approx. 10-15-fold increase in the EC50 values, whereas 8-bromo cyclic AMP was essentially without effect in the presence of insulin. Insulin binding was decreased by approx. 30-40% by N6-monobutyryl cyclic AMP, but no clear effect was seen with 8-bromo cyclic AMP (results not shown). The inhibitory effect of M-monobutyryl cyclic AMP on both insulin binding and insulinstimulated transport showed similar dose-response relationships; half-maximal effect was obtained at approx. 2 mM. 
DISCUSSION
This study confirms previous findings (Taylor et al., 1976; Green, 1983; Kirsch et al., 1983; Smith et al., 1984) that, in the absence of adenosine from the incubation medium, isoprenaline inhibits the stimulatory effect of a maximal insulin concentration on glucose transport. In addition, it is shown for the first time that isoprenaline and ADA together produce a marked rightward shift in the dose-response curve for insulin. This was associated with a gradual decrease in insulin binding. However, when insulin binding was studied under the same conditions as for glucose transport, i.e. after 20 min incubation, the decrease in insulin binding induced by isoprenaline and ADA was only 20-30%. Thus it is clear that the main reason for the marked decrease in insulin-sensitivity seen with these agents is due to post-receptor perturbations. It has been shown that ,6-adrenergic stimulation and cyclic AMP decrease the insulin-stimulated phosphorylation of the insulinreceptor tyrosine kinase (Hiiring et al., 1986; Stadtmauer & Rosen, 1986) . It is currently unclear, however, whether this finding may explain the marked insulinresistance in the cells exposed to ADA and isoprenaline. The additional decrease in insulin-sensitivity seen in cells from pertussis-toxin-treated animals with isoprenaline is probably in part due to the more marked decrease in insulin binding (Table 3) .
Pertussis toxin leads to an irreversible modification of the inhibitory nucleotide-binding protein (Ni) (Murayama & Ui, 1983) . The fact that Ni was modified by pertussis toxin under the conditions currently used was clearly shown by the loss of inhibitory effect of high GTP concentrations on adenylate cyclase activity, as well as by the lack of effect of ADA in these cells. It is well recognized that adenosine exerts its action via Ni (Londos et al., 1980) . However, the fact that adipocytes also contain the pertussis-toxin substrate No warrants some caution in attributing all the effects of the toxin to its action on Ni (Neer et al., 1984) . Although basal and insulin-stimulated rates of glucose transport were lower in pertussis-toxin-treated cells, the incremental effect of insulin was unchanged. This latter finding would preclude cell damage or other non-specific effects of pertussis toxin as a cause for the lower rates of glucose transport. Moreover, the data strongly support the concept that Ni does not mediate insulin action under normal conditions (Moreno et al., 1983) . The inhibitory effect of isoprenaline and the important modulating effect exerted by Ni on both insulin binding and insulin-stimulated glucose transport strongly suggest that these effects are cyclic-AMP-dependent. The marked shift in the dose-response curve for insulin in the presence of either isoprenaline and ADA or N6-monobutyryl cyclic AMP supports this possibility.
However, also non-cyclic-AMP-mediated effects of adenosine and Ni on glucose transport seem to be involved, since isoprenaline and ADA consistently decreased maximally insulin-stimulated glucose transport, whereas N6-monobutyryl cyclic AMP was essentially without effect on this parameter. A marked inhibitory effect of isoprenaline alone was seen in pertussis-toxin-treated cells. Taken together, these findings indicate that the decreased insulin-responsiveness seen with isoprenaline and ADA in control cells or with isoprenaline alone in pertussis-toxin-treated cells is, in contrast with the effect on insulin-sensitivity, largely attributable to a cyclic-AMP-independent mechanism elicited by withdrawal of adenosine and NI.
The importance of non-cyclic-AMP-mediated effects for the insulin-antagonistic action of isoprenaline and ADA in rat adipocytes has been further substantiated by Simpson et al. (1985) , who reported that the inhibition was overcome by adenosine analogues without any concomitant decrease in cyclic-AMP-dependent protein kinase activity. However, the interaction between N1 stimulation and insulin is complex, as adenosine analogues binding to the R-type receptors restore the ability of insulin to activate the phosphodiesterase, even in the presence of counter-regulatory hormones (Elks et al., 1983; Wallace et al., 1984; Heyworth et al., 1984 Heyworth et al., , 1986 . It is not clear whether such an effect is associated with a lower protein kinase activity. Furthermore, the ability of insulin to overcome the antagonistic effect of 8-bromo cyclic AMP is maintained in pertussis-toxintreated cells (results not shown).
The importance of phosphodiesterase activation for the ability of insulin to stimulate glucose transport during 8-adrenergic stimulation was evaluated by comparing the insulin-antagonistic effects of M-monobutyryl cyclic AMP and 8-bromo cyclic AMP. The former analogue is resistant to hydrolysis by phosphodiesterase, but the latter is an excellent substrate (Beebe et al., 1984) . The results of those experiments clearly showed that phosphodiesterase activation is necessary to elicit insulin action when cyclic AMP concentrations are elevated. Moreover, the similar EC50 value for the effect of insulin to overcome the inhibitory action of the cyclic AMP analogue and to stimulate glucose transport under conditions when the cellular cyclic AMP concentrations are high excludes important additional effects of insulin on cyclic AMP generation, such as inhibition of adenylate cyclase activity. The importance of the phosphodiesterase for insulin action is in agreement with the finding that phosphodiesterase activation is necessary for the hormone to elicit its anti-lipolytic effect .
In conclusion, fl-adrenergic stimulation and high cyclic AMP concentrations markedly decrease insulin-sensitivity through both receptor and post-receptor perturbations. However, insulin-responsiveness is influenced to a much smaller extent by cyclic AMP. The ability of insulin to modulate the cyclic AMP concentrations by activating the phosphodiesterase is a critical step for the hormone to elicit its effects. Furthermore, adenosine and probably other agents coupled to Ni seem to influence glucose transport through a non-cyclic-AMP-associated mechanism.
